Group 1 - Jicheng Electronics won a total of 15 bids from the State Grid Corporation, with a total bid amount of approximately 215 million yuan, accounting for 8.27% of the company's projected revenue for 2024 [2] - Jianmin Group's chemical generic drug, Ambrutoro Oral Solution, has been approved for market launch by the National Medical Products Administration, aimed at treating cough and wheezing caused by chronic bronchitis and emphysema [3] - Taiji Industry's subsidiary plans to transfer accounts receivable not exceeding 85 million USD to optimize cash flow, with an expected service fee of approximately 285,000 USD [4] Group 2 - Nanjing Pharmaceutical's subsidiary plans to invest 398 million yuan in a modern pharmaceutical logistics expansion project, with a construction period of approximately 35 months [5] - Ruili Kemi received a development notification from a well-known domestic flying car company to supply core components [6] - Ding Tong Technology announced that several executives plan to reduce their holdings by a total of no more than 45,300 shares, representing about 0.032% of the total share capital [7][8] Group 3 - Ninghu Expressway's subsidiary plans to invest no more than 9.033 billion yuan in the construction of the Nanyang Yangtze River Bridge South Connection Project [10] - Wuliangye announced a mid-term profit distribution plan for 2025, proposing a cash dividend of 25.78 yuan per 10 shares, totaling approximately 10 billion yuan [12] - Beixin Road and Bridge's subsidiary won a bid for a project worth 180 million yuan [14] Group 4 - Minhe Livestock reported a 7.75% month-on-month increase in sales revenue from commodity chick sales in November [15] - Xuelong Group plans to invest 100 million yuan to establish a wholly-owned subsidiary for vertical integration in the aluminum and magnesium technology sector [16] - Shengnong Development reported a 15.77% year-on-year increase in sales revenue in November, with significant growth in both poultry and processed meat products [17] Group 5 - Xingyu Co., Ltd. plans to repurchase shares worth 200 million to 300 million yuan for employee stock ownership plans [18] - Quan Chai Power intends to use 50 million yuan of idle funds to purchase structured deposit products [19] - Shibei High-tech appointed Zhao Junhong as the new deputy general manager [20] Group 6 - Fuan Pharmaceutical's subsidiary received a drug registration certificate for injectable isavuconazole, expanding its anti-infection product line [21] - Xiaoming Co. reported a 49.73% year-on-year decline in chicken product sales revenue in November [22] - Baiao Chemical adjusted its share repurchase price ceiling to no more than 48.95 yuan per share [23] Group 7 - Hefei China reported a 26.02% year-on-year decline in consolidated revenue for the first 11 months [24] - Laimei Pharmaceutical's subsidiary received medical device registration certificates for two endoscope products [25][26] - Xiantan Co. reported an 11.63% year-on-year increase in chicken product sales revenue in November [27] Group 8 - Qilin Security received government subsidies totaling 5.4014 million yuan [28] - Blue Sky Gas's controlling shareholder's 30.9134 million shares were judicially frozen, accounting for 4.33% of the total share capital [29] - Tieke Railway signed a contract for high-speed railway fasteners worth 654 million yuan, accounting for 41.08% of the company's projected revenue for 2024 [30] Group 9 - David Medical's electric surgical table received a medical device registration certificate [31] - Zhendong Pharmaceutical's affiliate's core product new drug application was accepted by the CDE [32] - Shanghai Pharmaceutical's apple acid sitagliptin tablet application for market approval was granted by the National Medical Products Administration [33] Group 10 - Nanjiao Food reported a 1.14% year-on-year increase in consolidated revenue for November [34]

格隆汇12月10日丨戴维医疗(300314.SZ)公布，新产品电动手术台获得了浙江省药品监督管理局颁发的 《医疗器械注册证》，电动手术台是手术治疗中不可缺少的基础医疗设备，主要用于支撑患者身体、调 整手术体位、充分暴露手术野，使医护人员在方便、舒适的条件下顺利完成各类手术。其核心价值是在 于是否安全舒适、好用且耐用。公司本次获注册的电动手术台，采用电动液压控制方式，通过微型按键 开关控制器灵活控制台面的各种运动，以满足手术所需的各种体位要求。可在任何体位下都具有高承重 的功能，能够满足手术的多变性和患者的不同体位。模块化设计的台面更能适用于多种多样的手术，简 单的按钮式连接关节使其操作更加简便。 ...

南财智讯12月10日电，戴维医疗公告，公司收到浙江省药品监督管理局颁发的《医疗器械注册证》，产 品名称为电动手术台，型号规格包括DT-100/DT-100A/DT-100B/DT-100C/DT-100D，注册分类为Ⅱ类， 有效期至2030年12月7日。适用范围为常规手术、神经外科、胸腹外科、骨科、泌尿外科肛肠科、整形 外科、妇科、肝胆外科及普外科手术等医疗过程的患者多体位支撑与操作。以上产品医疗器械注册证的 取得，有利于丰富公司产品线，进一步提高公司的核心竞争力，对公司未来的经营成果将产生积极影 响。目前尚无法预测该等产品对公司未来营业收入的影响，敬请投资者注意投资风险。 ...

戴维医疗12月10日公告，公司电动手术台获得浙江省药品监督管理局颁发的《医疗器械注册证》。本设 备用于常规手术、神经外科、胸腹外科、骨科、泌尿外科肛肠科、整形外科、妇科，肝胆外科及普外科 手术等医疗过程的患者 多体位支撑与操作，使其躺卧成不同的姿势。以上产品医疗器械注册证的取 得，有利于丰富公司产品线，进一步提高公司的核心竞争力，对公司未来的经营成果将产生积极影响。 目前尚无法预测该等产品对公司未来营业收入的影响。 ...

戴维医疗（300314）(300314.SZ)公告，公司新产品电动手术台获得了浙江省药品监督管理局颁发的 《医疗器械注册证》。 ...

智通财经APP讯，戴维医疗(300314.SZ)公告，公司新产品电动手术台获得了浙江省药品监督管理局颁发 的《医疗器械注册证》。 ...

新华社基加利9月18日电（记者吉莉）第25批中国援卢旺达医疗队18日向卢旺达东方省基本戈医院捐赠 一批医疗器械。 捐赠仪式上，中国医疗队向卢方捐赠了电动手术台、无影手术灯、妇科检查床等设备。 卢旺达东方省恩戈马地区区长尼约纳吉拉·纳塔莉对中方捐赠表示衷心感谢。她说，中国长期以来在基 础设施、教育、医疗等领域给予卢旺达宝贵支持，显著改善了当地民生。基本戈医院长期得到中方在人 力、技术和设备等方面的支持，1992年与中方合作完成扩建，目前正稳步朝着建成一所完整教学医院的 目标迈进。 中国援卢医疗队队长王永祥介绍说，此次捐赠的物资主要用于手术室和妇产科，将有助于提升医院手术 能力，改善患者就医条件。据介绍，过去9个月，第25批医疗队共完成手术702台，接诊患者万余人次， 组织5次义诊和健康宣教活动，并开展12次学术与文化交流。 自1982年以来，中国已派出25批、共324名医务人员赴卢旺达开展医疗援助，分别在马萨卡医院和基本 戈医院开展日常诊疗，累计接诊72万余人次，实施手术4万余台，挽救超过1.6万名危重患者生命。 中国驻卢旺达大使高文棋在致辞中表示，数十年来，中卢医疗合作广泛深入、成果丰硕。中国曾援建基 本戈医 ...

Group 1 - Huazhong Securities has been approved to issue subordinate corporate bonds with a total face value of no more than 10 billion yuan [1] - Jinbei Automotive plans to invest 240 million yuan to establish an automotive industry investment fund focusing on electrification, intelligence, and low carbon [1] - Linyang Energy is expected to win a bid for a 244 million yuan metering equipment project from Southern Power Grid [1][2] Group 2 - Renfu Pharmaceutical's subsidiary has received drug registration certificates for two products, including a medication for acute hypotension [3][4] - Nanjing Steel plans to distribute a cash dividend of 0.1186 yuan per share [5][6] - Pairui Co. has signed a strategic cooperation agreement with Xi'an Power Electronics Research Institute to develop power devices [7][8] Group 3 - Haixing Electric is expected to win a bid for a 214 million yuan metering equipment project from Southern Power Grid [9][10] - Kuangda Technology is planning a change in control, leading to a continued suspension of its stock [11][12] - Samsung Medical is expected to win a bid for a 274 million yuan metering equipment project from Southern Power Grid [13][14] Group 4 - Jiukang Bio has obtained a medical device registration certificate for a specific diagnostic kit [15][16] - Hechuan Technology's minority shareholder plans to transfer a 13% stake in a subsidiary [17][18] - DiAo Micro has launched a new eUSB2 repeater product for various electronic applications [19][20] Group 5 - David Medical's electric surgical table registration application has been accepted [21][22] - Hangxin Technology plans to apply for a total of 280 million yuan in bank credit [23][24] - Liyuan Technology's non-independent director has resigned [25][26] Group 6 - Ningbo Construction's subsidiary has won a construction project bid worth 729 million yuan [27][28] - Huaren Pharmaceutical's subsidiary has received approval for a raw material drug [29][30] - Suwen Electric plans to distribute a cash dividend of 1 yuan per 10 shares [31][32] Group 7 - Solar Energy has received 1.692 billion yuan in renewable energy subsidies [33][34] - Wangli Security has obtained a patent for a new lock structure [35][36] - Zhejiang Energy's vice chairman has resigned due to age reasons [37][38] Group 8 - Beilu Pharmaceutical's subsidiary has passed GMP certification in Brazil [39][40] - Zhejiang Communications has a subsidiary that is expected to win a highway project bid [41][42] - Xinzhi Group has received a government subsidy of 11.1978 million yuan [43][44] Group 9 - Dong'an Power's engine sales in August increased by 3.44% year-on-year [45][46] - Baiyun Mountain's subsidiary has passed the consistency evaluation for two generic drugs [47][48] - Yipin Hong's subsidiary has received a drug registration certificate for a specific injection [49][50] Group 10 - Far East Holdings' subsidiary has won multiple contracts totaling 1.689 billion yuan [51][52] - Good Housekeeping's shareholder plans to reduce holdings by up to 3.5 million shares [53][54] - Guanghong Technology's shareholders have set a transfer price of 23.33 yuan per share [55][56] Group 11 - Keli Sensor plans to acquire 45% of Huahong Technology's shares for 122 million yuan [57][58] - Jianmin Group's furosemide oral solution has been approved for market launch [59][60] - Jinghua Laser's directors plan to reduce their holdings by up to 143,420 shares [61][62] Group 12 - Zhuyue Group is planning a share transfer that will change its controlling shareholder [63][64] - Terid has pre-bid for two projects totaling approximately 698 million yuan [65][66] - Zhonghuan Hailu is planning a change in control, leading to a continued suspension of its stock and convertible bonds [67][68] Group 13 - Great Wall Motors reported August sales of 115,600 vehicles, a year-on-year increase of 22.33% [69][70] - Guizhou Tire's controlling shareholder has committed not to reduce holdings for 12 months [71][72] - San Da Membrane's shareholder plans to reduce holdings by up to 1% of the company's shares [73][74] Group 14 - Chint Electric has decided to terminate the spin-off of its subsidiary for listing [75][76] - Jusaylong's shareholder plans to reduce holdings by up to 1% of the company's shares [77][78]

Group 1 - The company, David Medical, announced that it has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for its product, an electric surgical table [2] - The acceptance number for the product is: 20254028265 [2] - This development indicates a significant step in the regulatory process for the company's medical equipment [2]

Core Viewpoint - David Medical (300314.SZ) has recently obtained a "Notice of Acceptance" issued by the Zhejiang Provincial Drug Administration for its product, an electric surgical table [1] Group 1 - The company has received regulatory approval for a new medical device, indicating progress in its product development pipeline [1] - The electric surgical table is expected to enhance operational efficiency in surgical settings, potentially increasing the company's market competitiveness [1]